[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Celldex Therapeutics, Inc (CLDX)
Celldex Therapeutics (CLDX) sees positive data and analyst 'Buy' ratings, with engagements up significantly. The stock is trading at $24.80, reflecting a bullish trend despite volatility concerns.
About Celldex Therapeutics, Inc
Celldex Therapeutics, Inc. (CLDX) is a biotechnology company focused on developing innovative therapies for cancer and other diseases.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Celldex Therapeutics, Inc (CLDX) trading volume is up XXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) social dominance is up XXXXXX% from the previous month.
- Celldex Therapeutics, Inc (CLDX) galaxy score™ is up XXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) engagements is up XXXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) posts created is up XXXXX% from the previous week.
- Celldex Therapeutics, Inc Price hit a 52-Week high of XXXXX for the hour
Price: $XX #
Price 24-Hour Time-Series Raw Data
The current price of $XXXXX appears to be influenced by positive trial data, analyst ratings, and overall biotech momentum, as well as the recent increase in engagements and posts, coupled with positive sentiment, suggesting a bullish trend, despite some concerns about volatility.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | XXXX% | XXXXX% |
1-Year High: $XXXXX on 2024-10-16
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #458 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXXXX -XXX
1 Month: XXX -XXX
6 Months: XXX -XX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-09-04
1-Year Low: XX on 2024-12-28
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +3
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-04-11
1-Year Low: X on 2025-08-28
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX +151%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX +55%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-06-13
1-Year Low: XX on 2025-04-13
| Social Network | X | TikTok |
|---|---|---|
| Engagements | XXX | X |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +41%
1 Year: XXXXX +57%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13
| Social Network | X | TikTok |
|---|---|---|
| Mentions | XX | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +123%
1 Year: XXXXX +87%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13
The most influential creators that mention Celldex Therapeutics, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @semodough | X | XXXXXX | X | XXX |
| @SteveDJacobs | X | XXXXX | X | XX |
| @MarcJacksonLA | X | XXXXX | X | XX |
| @doepke_michel | X | XXXXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +25%
6 Months: XX% +8%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-16
1-Year Low: XX% on 2025-02-08
Most Supportive Themes
- Positive Trial Data and Biotech Momentum: (35%) Posts highlight positive trial data and the overall positive momentum within the biotech sector, suggesting optimism for Celldex Therapeutics.
- Analyst Ratings and Price Targets: (25%) Mentions of analyst ratings and price targets, with some analysts reiterating 'Buy' ratings and setting higher price targets for CLDX.
- Product Advancements and Partnerships: (15%) News about advancements in treatments like Dupixent and partnerships, indicating potential growth and market expansion for Celldex.
Most Critical Themes
- Price Volatility and Market Cap Concerns: (10%) Some posts mention the stock's volatility and the current market cap, with one post suggesting the stock is being 'pumped' and could be a meme stock.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | X | X% |
| TikTok | X | X% | X | X% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00155%
1 Month: XXXXXX% +0.0031%
6 Months: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
1 Year: XXXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-10-22
1-Year Low: XXXXX% on 2025-09-14
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-09
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.95%
1 Month: $XXXXXXXXXXXXX +$8%
6 Months: $XXXXXXXXXXXXX +$45%
1 Year: $XXXXXXXXXXXXX -$9.80%
1-Year High: $XXXXXXXXXXXXX on 2024-10-16
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Celldex Therapeutics, Inc in the last XX hours
Sanofi (SNY) AAR Corp. (AIR) Century Aluminum Co (CENX) Critical Metals Corp. Ordinary Shares (CRML) A3S Protocol (AA) Alcoa, Corp. (AA) Arcellx, Inc. Common Stock (ACLX) ATAI Life Sciences (ATAI) Blueprint Medicines Corporation (BPMC)
Top topics mentioned In the posts about Celldex Therapeutics, Inc in the last XX hours
stocks healthcare, stocks bitcoin treasuries, stocks, $abvx, $anab, stocks basic materials, sanofi, stocks technology, $barcl, $cmpr, $air, $cenx, stocks real estate, $crvs, $crml, $aa, alcoa corp, coins arbitrum, $aclx, atai life, $bpmc, $sny, regeneron pharmaceuticals inc, morgan stanley, stocks financial services, $clne, $coya, $bldax, tesla, $mnpr, $cogt, $pfe, targets, acquisition, $nuvb, $rogsw, brad, $ag, $uamy, $lase, $brea, $cdlx, stocks consumer cyclical, $tjx, $flnt, stocks industrials, albemarle corp, $alb, $adpt, $bbio, $ptgx, $nktr, superrare, $aeis, $anet, $200m2b, $asst, $cdro, $cnr, $tmo, coins solana ecosystem, $adnt, $atai, $nvs, $bhvn, $jazz, $79k, $75k, $787k, $laes, $70m, $regn, $roiv, $orka, $eltx, $atxs, $nrix, $qubt, investment, $1241m, $936m, $zvra, $skin, $alhc, $nok, $bldp, $rlay, $kmda, $apld
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Triple Digit Upside Calls Today $BLDP with XXX% upside 🚀 $RLAY $KMDA $CLDX all showing 100%+ potential 💯 $APLD riding AI wave with XX% target 🤖 Analysts going big #StocksRunner #TradingView #Upside"
X Link @stocks_runner 2025-10-14T21:03Z XX followers, XX engagements
"$CLDX -Barclays initiates Celldex Therapeutics coverage at Underweight due to concerns about limited upside potential through year-end 2026 -Sets $XX target"
X Link @MarcJacksonLA 2025-10-13T17:11Z 7566 followers, XXX engagements
"$ABVX $ANAB $CLDX $CRVS $MNPR $ORKA $RAPT $TVRD Barclays initiates coverage on U.S. small & mid-cap biotech stocks"
X Link @MarcJacksonLA 2025-10-13T15:52Z 7566 followers, XXX engagements
"Barclays - new #Biotech analyst Etzer Darout - was at BMO now at Barclays New Coverage Offers Opportunity to Participate in Biotech Upside Opportunities Abound as We Look to Next Waves of Innovation in Biotech. initiate coverage on $ABVX $ANAB $CLDX $CRVS MNPR ORKA RAPT and TVRD"
X Link @semodough 2025-10-13T14:45Z 41.4K followers, 7998 engagements